FONAR Corporation logo
FONAR Corporation FONR
$ 18.35 0.05%

Quarterly report 2025-Q4
added 02-13-2026

report update icon

FONAR Corporation Financial Statements 2011-2026 | FONR

Annual Financial Statements FONAR Corporation

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

85.2 M 91.1 M 158 M 154 M 163 M 170 M 144 M 64.3 M 68 M 35.5 M 20.3 M 10.4 M

Shares

6.55 M 6.51 M 6.44 M 6.35 M 6.29 M 6.54 M 6.43 M 6.43 M 6.39 M 6.06 M 5.78 M 5.26 M

Historical Prices

13.7 15 17.4 19.7 20.2 24.4 19.1 17.3 10.4 21.2 4.33 1.7

Net Income

12.4 M 10.2 M 8.24 M 15.3 M 21.2 M 19.6 M 15.7 M 12.9 M 10.4 M 8.68 M 5.78 M 3.16 M

Revenue

97.6 M 89.9 M 85.7 M 87.2 M 81.5 M 78 M 73.4 M 69.1 M 68.5 M 49.1 M 39.4 M 33.1 M

Gross Profit

- - 42.4 M 43.2 M 39.6 M 40 M 34.5 M 30.6 M 31.3 M 23 M 18.2 M 14.7 M

Operating Income

5.31 M -7.09 M - - - - - - - - - -

Interest Expense

347 K 249 K 74.3 K 98.6 K -160 K 28.3 K -262 K -702 K -885 K -500 K 479 K 515 K

EBITDA

9.84 M -3.01 M 18.6 M 26 M 23.6 M 22.6 M 17.7 M 16.4 M 16.1 M 9.96 M 9.44 M 5.86 M

Operating Expenses

- - 28.7 M 21.1 M 19.9 M 20.9 M 20.1 M 17.7 M 19 M 15.5 M 11 M 10.9 M

General and Administrative Expenses

23.5 M 24.7 M 26.7 M 19.3 M 18.1 M 19.4 M 18.5 M 13.5 M 15.4 M 12.5 M 8.75 M 8.46 M

All numbers in USD currency

Quarterly Income Statement FONAR Corporation

2025-Q4 2025-Q3 2025-Q1 2024-Q4 2024-Q3 2024-Q1 2023-Q4 2023-Q3 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

6.86 M 6.86 M 6.86 M 7 M 6.3 M 7.03 M 6.44 M 6.41 M 6.48 M 6.53 M 6.54 M 6.53 M 6.55 M 6.55 M 6.55 M 6.55 M 6.55 M 6.46 M 6.45 M 6.46 M 6.45 M 6.45 M 6.43 M 6.45 M 6.43 M 6.36 M 6.34 M 6.36 M 6.34 M 6.29 M 6.29 M 6.29 M 6.29 M 6.16 M 6.1 M 6.16 M 6.1 M 6.05 M 6.05 M 6.05 M 6.05 M 6.05 M 6.05 M 6.05 M 6.05 M 6.01 M 5.98 M 5.99 M 5.94 M 5.93 M 5.9 M 5.93 K 5.9 K 5.73 K 5.67 K - -

Net Income

2.06 M 2.26 M 2.51 M 1.96 M 3.14 M 1.87 M 3.76 M 4.11 M 3.86 M 2.23 M 2.05 M 4.28 M 2.29 M 4.02 M 3.89 M 7.91 M 3.87 M 3.11 M 2.51 M 3.11 M 2.51 M 3.1 M 3.3 M 3.1 M 3.3 M 3.55 M 3.32 M 3.55 M 3.32 M 4.19 M 3.72 M 4.19 M 3.72 M 4.24 M 3.57 M 4.24 M 3.57 M 3.49 M 2.86 M 3.49 M 2.86 M 2.66 M 2.54 M 2.66 M 2.54 M 2.14 M 2.44 M 2.14 M 2.44 M 1.35 M 1.45 M 1.35 M 1.45 M 1.54 M 1.51 M 1.54 M 1.51 M

Revenue

25.5 M 26 M 27.2 M 25 M 25 M 25.7 M 25.4 M 25.8 M 25.4 M 24.3 M 23.2 M 47.4 M 24.6 M 24.5 M 23.7 M 48.2 M 23.1 M 21.2 M 21 M 219 K 219 K 219 K 219 K 219 K 219 K 227 K 20.7 M 227 K 21 M 20.2 M 19.3 M 39.5 M 19.3 M 18.4 M 18.7 M 18.4 M 18.7 M 18.4 M 17.6 M 18.4 M 17.6 M 17.1 M 18 M 17.1 M 18 M 17.6 M 16.8 M 17.6 M 16.8 M 9.61 M 9.51 M 9.61 M 9.51 M 9.33 M 9.61 M 9.33 M 9.61 M

Interest Expense

3 K 3 K -1 K 1 K -1 K 45 K 10 K 48 K 15 K 12 K 14 K -197 K - 47 K 811 K 858 K 19 K 16 K 22 K 16 K 22 K 19 K 21 K -19 K -21 K -25 K -25 K -25 K -25 K -48 K -43 K -48 K -43 K -77 K -98 K -77 K -98 K -139 K -150 K 139 K 150 K 172 K 204 K 172 K 204 K 237 K 243 K 237 K 243 K 103 K 76 K 103 K 76 K 124 K 107 K 124 K 107 K

EBITDA

- - - - - - - - - 1.1 M 1.12 M 2.22 M 1.18 M 1.19 M 1.17 M 2.36 M 1.09 M 1.04 M 968 K 1.04 M 968 K 1.01 M 995 K 1.01 M 995 K 952 K 922 K 952 K 922 K 998 K 959 K 998 K 959 K 863 K 856 K 863 K 856 K 848 K 829 K 848 K 829 K 888 K 888 K 888 K 888 K 972 K 982 K 972 K 982 K 395 K 415 K 395 K 415 K 524 K 525 K 1.05 M 525 K

General and Administrative Expenses

6.24 M 6.81 M 7.99 M 6.93 M 5.13 M 7.59 M 5.59 M 4.87 M 7.14 M 6.6 M 6.33 M 12.9 M 6.07 M 4.77 M 5.09 M 9.86 M 6.11 M 4.54 M 6.16 M 4.54 M 6.16 M 4.16 M 4.29 M 4.16 M 4.29 M 3.61 M 4.26 M 3.61 M 4.26 M 3.29 M 4.08 M 3.29 M 4.08 M 4.07 M 4.06 M 4.07 M 4.06 M 3.87 M 4.19 M 4.12 M 3.78 M 3.82 M 3.58 M 3.82 M 3.58 M 4.35 M 3.74 M 4.35 M 3.74 M 2.35 M 2.21 M 2.35 M 2.21 M 2 M 2.04 M 2 M 2.04 M

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements FONAR Corporation FONR
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting FONAR Corporation plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
Alphatec Holdings Alphatec Holdings
ATEC
$ 11.9 -2.06 % $ 1.79 B usaUSA
Butterfly Network Butterfly Network
BFLY
$ 4.29 2.39 % $ 908 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 62.99 -0.4 % $ 3.44 B britainBritain
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
LENSAR LENSAR
LNSR
$ 5.72 -5.85 % $ 65.9 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.35 -0.22 % $ 21.8 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 87.15 -0.07 % $ 112 B usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
AxoGen AxoGen
AXGN
$ 32.23 1.51 % $ 1.48 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 36.47 -0.44 % $ 1.13 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Electromed Electromed
ELMD
$ 24.44 -0.2 % $ 207 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.68 0.86 % $ 37 M usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 2.24 -2.61 % $ 3.5 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Orthofix Medical Orthofix Medical
OFIX
$ 11.9 0.25 % $ 471 M curacaoCuracao
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 11.04 6.41 % $ 1.49 B usaUSA
Myomo Myomo
MYO
$ 0.72 2.1 % $ 30.1 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 99.94 0.75 % $ 1.27 B usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
$ 2.36 -3.28 % $ 138 M israelIsrael
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.85 3.08 % $ 144 M franceFrance
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 16.26 -1.28 % $ 381 M usaUSA
Penumbra Penumbra
PEN
$ 335.06 -0.15 % $ 13 B usaUSA
Outset Medical Outset Medical
OM
$ 3.51 -3.04 % $ 53.4 K usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 51.85 -0.69 % $ 1.52 B usaUSA
Insulet Corporation Insulet Corporation
PODD
$ 225.55 -0.68 % $ 15.9 B usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
$ 5.16 -4.44 % $ 180 M canadaCanada
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 1.38 -1.08 % $ 56.1 M usaUSA
Quanterix Corporation Quanterix Corporation
QTRX
$ 3.75 -4.82 % $ 160 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
InspireMD InspireMD
NSPR
$ 1.79 3.47 % $ 115 M israelIsrael